Highlights S2Medical AB

Equities

S2M

SE0011725084

Market Closed - Nasdaq Stockholm Other stock markets 16:29:59 07/06/2024 BST			5-day change	1st Jan Change
0.036 ^SEK	-25.00%		-32.46%	-40.00%

05-17	S2Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-20	S2Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

S2Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-17	CI
S2Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-20	CI
S2Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-20	CI
S2Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-17	CI
S2medical AB Signs Exclusive Distribution Agreement with Provas Medical Ltd for the Turkey Market	11-06	CI
S2Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/08/23	CI
S2medical AB Signs Manufacturing Agreement with Distributor in Saudi Arabia	08/06/23	CI
S2Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	31/05/23	CI
S2Medical AB Signs Distribution Agreement for Iranian Market with Avije Teb Parsin	17/05/23	CI
S2Medical AB Wins Procurement for Wound Healing Items in the United Arab Emirates Worth Approximately SEK 3.4 Million	21/04/23	CI
S2Medical AB Wins Procurement for Wound Healing Equipment in Region Halland	03/03/23	CI
S2Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	22/02/23	CI
S2Medical AB Announces the Positive Outcome of Antimicrobial Peptides Tests Against the Multi Resistant Bacteria	02/01/23	CI
S2Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22	CI
S2Medical Set to Win Europe Patent for Antimicrobial Peptides Technology	14/10/22	MT
EPO Announces Intention to Approve Patenting of S2Medical AB's AMP Technology	14/10/22	CI
Region Östergötland Signs Direct Purchase Agreement for its within S2Mededical's Wound Healing Portfolio	14/10/22	CI
S2Medical AB Announces Positive outcome from evaluation of Epiprotect in Saudi Arabia	28/09/22	CI
S2Medical Enters Exclusive Deal with Molecular Farma for Portugal Distribution	23/09/22	MT
S2medical Ab: S2medical AB Signs Exclusive Distribution Agreement for Portugal	23/09/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights S2Medical AB

Equities

S2M

SE0011725084

Highlights

Filters